Amy Schacterle's most recent trade in Acumen Pharmaceuticals Inc was a trade of 13,200 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acumen Pharmaceuticals Inc | Amy Schacterle | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 13,200 | 13,200 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Amy Schacterle | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 8,800 | 8,800 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Amy Schacterle | Chief Regulatory Officer | 05 Nov 2024 | 340,000 | 340,000 | - | - | Employee Stock Option (right to buy) |